Evidence map›Paper›PMID 36091110›Full record

ArticleFrontiers in oncology2022

Machine learning prediction of prostate cancer from transrectal ultrasound video clips.

Kai Wang, Peizhe Chen, Bojian Feng, Jing Tu, Zhengbiao Hu, Maoliang Zhang, Jie Yang, Ying Zhan, Jincao Yao, Dong Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Artificial intelligence applications in prostate cancer.Prostate cancer and prostatic diseases · 2024
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Kai WangDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Peizhe ChenCollege of Optical Science and Engineering, Zhejiang University, Hangzhou, China.
Bojian FengDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Jing TuDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Zhengbiao HuDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Maoliang ZhangDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Jie YangDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Ying ZhanDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Jincao YaoDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Dong XuDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Wenzhou Medical University · CNZhejiang Cancer Hospital · CNChinese Academy of Sciences · CNDongyang People's Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To build a machine learning (ML) prediction model for prostate cancer (PCa) from transrectal ultrasound video clips of the whole prostate gland, diagnostic performance was compared with magnetic resonance imaging (MRI). Methods: We systematically collated data from 501 patients-276 with prostate cancer and 225 with benign lesions. From a final selection of 231 patients (118 with prostate cancer and 113 with benign lesions), we randomly chose 170 for the purpose of training and validating a machine learning model, while using the remaining 61 to test a derived model. We extracted 851 features from ultrasound video clips. After dimensionality reduction with the least absolute shrinkage and selection operator (LASSO) regression, 14 features were finally selected and the support vector machine (SVM) and random forest (RF) algorithms were used to establish radiomics models based on those features. In addition, we creatively proposed a machine learning models aided diagnosis algorithm (MLAD) composed of SVM, RF, and radiologists' diagnosis based on MRI to evaluate the performance of ML models in computer-aided diagnosis (CAD). We evaluated the area under the curve (AUC) as well as the sensitivity, specificity, and precision of the ML models and radiologists' diagnosis based on MRI by employing receiver operator characteristic curve (ROC) analysis. Results: The AUC, sensitivity, specificity, and precision of the SVM in the diagnosis of PCa in the validation set and the test set were 0.78, 63%, 80%; 0.75, 65%, and 67%, respectively. Additionally, the SVM model was found to be superior to senior radiologists' (SR, more than 10 years of experience) diagnosis based on MRI (AUC, 0.78 vs. 0.75 in the validation set and 0.75 vs. 0.72 in the test set), and the difference was statistically significant ( Conclusion: The prediction model constructed by the ML algorithm has good diagnostic efficiency for prostate cancer. The SVM model's diagnostic efficiency is superior to that of MRI, as it has a more focused application value. Overall, these prediction models can aid radiologists in making better diagnoses.

Indexed as

artificial intelligencemachine learningprostate cancersupport vector machineultrasound

Identifiers

PMID36091110
PMCPMC9459141
OpenAlexW4293194457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.